OKYO Pharma Statistics

Total Valuation

OKYO Pharma has a market cap or net worth of $34.51 million. The enterprise value is $34.36 million.

Market Cap	34.51M
Enterprise Value	34.36M

Important Dates

The next estimated earnings date is Friday, December 13, 2024, before market open.

Earnings Date	Dec 13, 2024
Ex-Dividend Date	n/a

Share Statistics

OKYO Pharma has 33.84 million shares outstanding. The number of shares has increased by 72.88% in one year.

Current Share Class	33.84M
Shares Outstanding	33.84M
Shares Change (YoY)	+72.88%
Shares Change (QoQ)	+5.67%
Owned by Insiders (%)	29.30%
Owned by Institutions (%)	2.96%
Float	23.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.21

Current Ratio	0.21
Quick Ratio	0.19
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-14.95

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-291.87%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$5.61M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, OKYO Pharma has paid $22,416 in taxes.

Income Tax	22,416
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.14% in the last 52 weeks. The beta is -3.37, so OKYO Pharma's price volatility has been lower than the market average.

Beta (5Y)	-3.37
52-Week Price Change	-38.14%
50-Day Moving Average	1.07
200-Day Moving Average	1.26
Relative Strength Index (RSI)	44.08
Average Volume (20 Days)	39,537

Short Selling Information

The latest short interest is 234,320, so 0.69% of the outstanding shares have been sold short.

Short Interest	234,320
Short Previous Month	271,996
Short % of Shares Out	0.69%
Short % of Float	0.98%
Short Ratio (days to cover)	2.83

Income Statement

Revenue	n/a
Gross Profit	-7.51M
Operating Income	-15.75M
Pretax Income	-13.28M
Net Income	-16.83M
EBITDA	-15.75M
EBIT	-15.75M
Earnings Per Share (EPS)	-$0.57

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	826,848
Total Debt	n/a
Net Cash	826,848
Net Cash Per Share	$0.02
Equity (Book Value)	-5.88M
Book Value Per Share	-0.18
Working Capital	-5.88M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-9.49M
Capital Expenditures	n/a
Free Cash Flow	-9.49M
FCF Per Share	-$0.28

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OKYO Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-72.88%
Shareholder Yield	-72.88%
Earnings Yield	-47.81%
FCF Yield	-26.97%

Analyst Forecast

The average price target for OKYO Pharma is $7.00, which is 586.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	586.28%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on May 22, 2023. It was a reverse split with a ratio of 0.0153846:1.

Last Split Date	May 22, 2023
Split Type	Reverse
Split Ratio	0.0153846:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1